Wells Fargo & Company Third Harmonic Bio, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 9,102 shares of THRD stock, worth $93,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,102
Previous 8,711
4.49%
Holding current value
$93,932
Previous $113,000
8.85%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$113 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$59.6 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$45.1 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$32.8 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$30.5 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $416M